annual EBITDA:
-$196.60M-$55.19M(-39.03%)Summary
- As of today (June 23, 2025), NRIX annual EBITDA is -$196.60 million, with the most recent change of -$55.19 million (-39.03%) on November 30, 2024.
- During the last 3 years, NRIX annual EBITDA has fallen by -$84.80 million (-75.84%).
- NRIX annual EBITDA is now -2812.15% below its all-time high of -$6.75 million, reached on November 30, 2018.
Performance
NRIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$58.74M+$1.62M(+2.68%)Summary
- As of today (June 23, 2025), NRIX quarterly EBITDA is -$58.74 million, with the most recent change of +$1.62 million (+2.68%) on February 28, 2025.
- Over the past year, NRIX quarterly EBITDA has dropped by -$17.41 million (-42.11%).
- NRIX quarterly EBITDA is now -2756.81% below its all-time high of -$2.06 million, reached on August 31, 2019.
Performance
NRIX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$214.00M-$17.41M(-8.85%)Summary
- As of today (June 23, 2025), NRIX TTM EBITDA is -$214.00 million, with the most recent change of -$17.41 million (-8.85%) on February 28, 2025.
- Over the past year, NRIX TTM EBITDA has dropped by -$71.04 million (-49.69%).
- NRIX TTM EBITDA is now -10308.75% below its all-time high of -$2.06 million, reached on August 31, 2019.
Performance
NRIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NRIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.0% | -42.1% | -49.7% |
| 3 y3 years | -75.8% | -45.1% | -65.7% |
| 5 y5 years | -888.8% | -386.9% | -436.8% |
NRIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.8% | at low | -150.7% | +2.7% | -51.3% | at low |
| 5 y | 5-year | -888.8% | at low | -361.2% | +2.7% | -436.8% | at low |
| alltime | all time | -2812.2% | at low | -2756.8% | +2.7% | <-9999.0% | at low |
NRIX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2025 | - | -$58.74M(-2.7%) | -$214.00M(+8.9%) |
| Nov 2024 | -$196.60M(+39.0%) | -$60.35M(+19.6%) | -$196.60M(+10.6%) |
| Aug 2024 | - | -$50.47M(+13.5%) | -$177.82M(+8.4%) |
| May 2024 | - | -$44.45M(+7.5%) | -$163.99M(+14.7%) |
| Feb 2024 | - | -$41.33M(-0.6%) | -$142.97M(+1.1%) |
| Nov 2023 | -$141.41M(-18.3%) | -$41.58M(+13.5%) | -$141.41M(-2.8%) |
| Aug 2023 | - | -$36.63M(+56.3%) | -$145.49M(-4.7%) |
| May 2023 | - | -$23.43M(-41.1%) | -$152.69M(-11.4%) |
| Feb 2023 | - | -$39.77M(-12.9%) | -$172.34M(-0.4%) |
| Nov 2022 | -$173.06M | -$45.65M(+4.2%) | -$173.06M(+5.7%) |
| Aug 2022 | - | -$43.83M(+1.7%) | -$163.75M(+11.2%) |
| May 2022 | - | -$43.08M(+6.4%) | -$147.31M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | -$40.49M(+11.4%) | -$129.16M(+15.5%) |
| Nov 2021 | -$111.80M(+78.0%) | -$36.34M(+32.7%) | -$111.80M(+17.9%) |
| Aug 2021 | - | -$27.39M(+9.8%) | -$94.83M(+10.2%) |
| May 2021 | - | -$24.93M(+7.8%) | -$86.08M(+16.5%) |
| Feb 2021 | - | -$23.14M(+19.5%) | -$73.88M(+17.6%) |
| Nov 2020 | -$62.80M(+215.9%) | -$19.36M(+3.9%) | -$62.80M(+11.2%) |
| Aug 2020 | - | -$18.64M(+46.4%) | -$56.45M(+41.6%) |
| May 2020 | - | -$12.73M(+5.6%) | -$39.87M(+46.9%) |
| Feb 2020 | - | -$12.06M(-7.3%) | -$27.13M(+80.0%) |
| Nov 2019 | -$19.88M(+194.5%) | -$13.02M(+533.0%) | -$15.07M(+633.0%) |
| Aug 2019 | - | -$2.06M | -$2.06M |
| Nov 2018 | -$6.75M | - | - |
FAQ
- What is Nurix Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Nurix Therapeutics?
- What is Nurix Therapeutics annual EBITDA year-on-year change?
- What is Nurix Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly EBITDA year-on-year change?
- What is Nurix Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Nurix Therapeutics?
- What is Nurix Therapeutics TTM EBITDA year-on-year change?
What is Nurix Therapeutics annual EBITDA?
The current annual EBITDA of NRIX is -$196.60M
What is the all time high annual EBITDA for Nurix Therapeutics?
Nurix Therapeutics all-time high annual EBITDA is -$6.75M
What is Nurix Therapeutics annual EBITDA year-on-year change?
Over the past year, NRIX annual EBITDA has changed by -$55.19M (-39.03%)
What is Nurix Therapeutics quarterly EBITDA?
The current quarterly EBITDA of NRIX is -$58.74M
What is the all time high quarterly EBITDA for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly EBITDA is -$2.06M
What is Nurix Therapeutics quarterly EBITDA year-on-year change?
Over the past year, NRIX quarterly EBITDA has changed by -$17.41M (-42.11%)
What is Nurix Therapeutics TTM EBITDA?
The current TTM EBITDA of NRIX is -$214.00M
What is the all time high TTM EBITDA for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM EBITDA is -$2.06M
What is Nurix Therapeutics TTM EBITDA year-on-year change?
Over the past year, NRIX TTM EBITDA has changed by -$71.04M (-49.69%)